Thus, variations in rs2290602 in the PPARGC1A gene would be expected to affect lipid and glucose metabolism, and result in the development of NAFLD and NASH. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.